Download presentation
Presentation is loading. Please wait.
Published byDonald Banks Modified over 6 years ago
1
Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents Jordan Axelrad, Oren Bernheim, Jean-Frederic Colombel, Stefano Malerba, Ashwin Ananthakrishnan, Vijay Yajnik, Gila Hoffman, Manasi Agrawal, Dana Lukin, Amit Desai, Elisa McEachern, Brian Bosworth, Ellen Scherl, Andre Reyes, Hina Zaidi, Prashant Mudireddy, David DiCaprio, Keith Sultan, Burton Korelitz, Erwin Wang, Renee Williams, LeaAnn Chen, Seymour Katz, Steven Itzkowitz Clinical Gastroenterology and Hepatology Volume 14, Issue 1, Pages (January 2016) DOI: /j.cgh Copyright © 2016 AGA Institute Terms and Conditions
2
Figure 1 At 5 years, there was no significant difference in cancer-free survival between groups (P = .14). Clinical Gastroenterology and Hepatology , 58-64DOI: ( /j.cgh ) Copyright © 2016 AGA Institute Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.